Brief: Briacell Announces Insiders' Intention To Purchase Up To 10% Of Public Market Securities
16/12/2021 13:25
Dec 16 (Reuters) - Briacell Therapeutics Corp BCT.V :
* BRIACELL ANNOUNCES INSIDERS' INTENTION TO PURCHASE UP TO
10% OF
PUBLIC MARKET SECURITIES
* BRIACELL THERAPEUTICS CORP - INSIDERS INTEND TO ACQUIRE UP
TO
1.59 MILLION SHARES
Source text for Eikon: ID:nGNX8lYP15
Further company coverage: BCT.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Briacell Therapeutics
See all newsBrief: Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share
Brief: Briacell Receives Positive Recommendation From Data Safety Monitoring Board (Dsmb) For Phase 3 Study In Metastatic Breast Cancer
Brief: Briacell Expands Pipeline To Include An Ovarian Cancer Immunotherapy Candidate, Bria-Ova+™
Brief: Briacell Phase 3 Bria-Imt™ Study Enrollment Surpasses 230 Patients
Brief: Briacell Adds Nyu Langone Health’S Perlmutter Cancer Center As Clinical Site In Pivotal Phase 3 Breast Cancer Study